pediatric
GASTROENTEROLOGY
Probiotic strain of human origin,
breast milk!
BioGaia AB
BioGaia AB is a Swedish biotechnology company and world leader in probiotics with experience and expertise of over 30 years and strong innovation profile.To date, BioGaia AB has in its possession more than 550 patents, commercial presence in more than 100 countries and a natural presence in Europe, USA, China and Japan. BioGaia's vision is peoples' health improvement, by offering probiotic products clinically documented and proven for their safety and effectiveness by age group and by disorder". Until now (2/2020) BioGaia AB has completed more than 217 clinical studies, in babies, children and adults and has proven the safety and efficacy of its probiotic products in several disorders.
®
BioGaia Protectis
BioGaia Protectis range of probiotic products contains the most studied - in infants and children - probiotic strain, the patented lactic acid bacterium strain Lactobacillus reuteri Protectis (DSM 17938) This extensively studied probiotic strain has been proven to protect from and treat the most common and upsetting functional gastrointestinal disorders in infants (infant colic, constipation and regurgitation) and also the functional abdominal pain in preschool and school aged children. BioGaia Protectis
®
®
®
has been proven in infants and children, that it maintains a healthier microbiota, reduces the risk of infections and offers an overall better quality of life. It also supports the immune system and helps infants and children with acute gastroenteritis to reduce the associated symptoms and recover faster from diarrhea and vomiting.
55
Patents
granted
100
Countries
presence
103
Clinical
studies
WHAT ARE PROBIOTICS
Probiotics are good bacteria that are found in food or supplements. The definition is ”Live microorganisms that, when administered in adequate amounts, confer a health benefit on the host.
"Positive results should be related to strain and should not be generalized for the species or attributed to other strains" (WHO/FAO, 2002)
Important criteria for qualifying as a true probiotic is that health benefits should be proven in clinical trials. Furthermore, a probiotic product must contain the same bacterial strain(s) and the same dose that was used in the clinical trials.
"When looking for a probiotic product, look for the strain. This is where value -if any, based on clinical evidence only - lies."
...evolve, focus, isolate, study, prove, evolve...
Dogs are living species.
But not all are the same.
Breed defines their characteristics.
Probiotics are living species
as well. Strain defines their characteristics!
BioGaia Protectis and BioGaia Protectis + D3 , belong to a family of probiotic products that contain the patented lactic acid bacteria strain L. reuteri Protectis (DSM 17938).
BioGaia Protectis has been extensively studied in infants and children and has been proven to be safe and significantly effective in the following most common pediatric gastrointestinal disorders:
• Colics
• Functional constipation
• Regurgitation
• Gastroenteritis
• Antibiotic associated side effects
• Functional abdominal pain
BioGaia Protectis + D3 has also been proven to be effective in:
• Immunity / Infection protection
• Vitamin D deficiency
®
®
®
®
®
Click on the picture for more information (currently in Greek only)
Worldwide 1st
30 years leading the way of probiotics
First probiotic chewable tablets (2000)
First probiotic drops (2004)
First 3 in 1 ORS (2009)
It's natural
We developed the 1st probiotic of human origin isolated from human breast milk
Multi-action
The probiotic with an excessively studied mode of action and a proven excellent communication and interaction with its host
Immunity
The probiotic that secures a well-functioning microbiota, a tight mucosa and an adequate immune response through a natural and clinically proven mode of action.
Colonisation
The only probiotic with
proven ability to colonize the entire Gastrointestinal Tract. In combination with its multiple mode of action, it offers a solution to a variety of gastrointestinal disorders
Active defence
The only probiotic that produces the well proven, natural, broad spectrum antipathogen factor reuterin
We are born with it
We developed a probiotic that is a natural habitat of our gastrointestinal tract from birth
Gut mobility
The probiotic that improves gut motility by promoting gastric emptying and regulating transit from small and large intestines to favor digestion and promote defecation
Passive defence
The probiotic that makes the epithelial lining stronger, tighter and better performing, preventing toxins and pathogens from passing through our digestive system into our body and bloodstream
The most studied
We isolated, developed, and proved the safety and efficacy of the world's most studied probiotic in pediatric population
Visceral pain
The only probiotic that has been proven to intervene into the gut – brain axis continuous communication in favor of the host, by reducing pain sensation
Even more safe
The probiotic that does not transfer its antibiotic resistance to other bacteria, preventing
from a critical global problem, the antibiotic resistance
WHEN, HOW & WHAT
SHOULD I USE?
I NEED TO SEE
biogaia IN THE world
I need some more
information
PLEASE FEEL FREE TO VISIT
Lacteeze
®
Lacteeze contains lactase enzyme which upon administration allows babies, children and adults with lactose intolerance to digest dairy containing foods again, without suffering from unpleasant symptoms such as bloating, flatulence, abdominal pain and diarrhea.
Under normal conditions lactase enzyme is produced at the small intestine. It's purpose is to break down lactose (a type of sugar found naturally in the milk of most mammals) so to become digestible. If lactose production in the small intestine is insufficient or absent (a very rare disorder) the digestion is interrupted and lactose
received through meals becomes an undigestible sugar that triggers a variety of disturbances as such as those described above.
®
PLEASE FEEL FREE TO VISIT
WHEN, HOW & WHAT
SHOULD I USE?
I need some more
information
LACTOSE INTOLERANCE
A PROBLEM FOR 3 OUT OF 10 CHILDREN
Click on the picture for more information (currently in Greek only)